The Ted Rogers Centre for Heart Research is committed to funding high-value, high-potential research projects with strong scientific merit and align with a core vision of ultimately transforming the care of children and adults with heart failure (click for definition).
The Centre’s Innovation Fund – comprising strategic grants and seed grants – guides the discovery and development of novel therapies and approaches to treating heart failure.
By supporting bench research, proof-of-concept development and the clinical assessment of new diagnostics, therapeutics and technologies, this fund plays a vital role in getting great ideas off the ground and enabling researchers to attract additional support and momentum for moving their innovations into the clinical and commercial spheres.
Leveraging the best technologies and methodologies available, awarded projects show the greatest potential to transform cardiac care. While they must involve at least 2 of the Centre’s 3 partner institutions, any partners worldwide may be co-applicants.
Special COVID-19 FUNDING OPPORTUNITY
In spring 2020, we opened a new funding opportunity for innovative, high priority research on the cardiovascular complications of COVID-19.
For this rapid funding opportunity, up to $500,000, projects were to focus on cardiovascular (CV) complications of COVID-19, examples of which may include innovations in: (i) identification of patients at high risk of developing CV related complications; (ii) early detection of CV complications in patients with COVID-19; (iii) prevention of CV related complications in patients with COVID-19; (iv) treatment or management of CV complications in patients with COVID-19 including longer term sequelae and follow up.
I) Seed Grants
2nd Competition – 2018/2019
The Centre’s second Innovation Fund seed grant competition closed in spring 2019. Seed Grants provide up to $100,000/year (renewable for one year) to support innovative research projects focused on transforming our understanding or approach to heart failure. Awardees shared bold ideas for solving key challenges in heart failure.
1st Competition – 2015/2016
The Centre’s first Innovation Fund seed grant competition launched in late October 2015, as a joint call with Medicine by Design. After the letter of intent stage, 15 applicants were selected to submit full applications. Of these, three seed grants were awarded in early 2016.
LOIs received: 43
Applications invited: 14
Seed grants awarded: 3
Success rate: 21%
II) Strategic Grants
The Strategic Grants competition, which began in 2018, provides funding of up to $1 million over 3 years for transformative research projects focused on discovery, development and implementation of next-generation approaches and therapies to address heart failure.
LOIs received: 16
Applications invited: 6
Strategic grants awarded: 2
Success rate: 33%